Published in Nat Med on September 01, 2012
Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science (2013) 3.74
IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. Nature (2014) 2.12
Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol (2013) 2.10
The multifaceted functions of neutrophils. Annu Rev Pathol (2013) 1.97
Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci (2013) 1.77
Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol (2013) 1.64
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest (2013) 1.60
C-type lectins in immunity: recent developments. Curr Opin Immunol (2014) 1.31
Complement--tapping into new sites and effector systems. Nat Rev Immunol (2014) 1.30
Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J (2013) 1.26
Glycoproteomic analysis of antibodies. Mol Cell Proteomics (2013) 1.19
Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep (2014) 1.06
T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J Clin Invest (2013) 1.06
B cells and their mediators as targets for therapy in solid tumors. Exp Cell Res (2013) 1.06
Nucleic acids and endosomal pattern recognition: how to tell friend from foe? Front Cell Infect Microbiol (2013) 1.04
Glycotherapy: new advances inspire a reemergence of glycans in medicine. Chem Biol (2013) 1.04
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood (2013) 1.03
Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm Bowel Dis (2015) 1.00
Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology (2015) 0.99
Complement in disease: a defence system turning offensive. Nat Rev Nephrol (2016) 0.97
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS One (2013) 0.94
The regulatory power of glycans and their binding partners in immunity. Trends Immunol (2013) 0.93
Opportunities to exploit non-neutralizing HIV-specific antibody activity. Curr HIV Res (2013) 0.91
Highly parallel characterization of IgG Fc binding interactions. MAbs (2014) 0.89
Dectin immunoadhesins and pneumocystis pneumonia. Infect Immun (2013) 0.88
Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol (2013) 0.88
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics (2015) 0.88
Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling. Immunol Rev (2015) 0.87
Engineering broadly neutralizing antibodies for HIV prevention and therapy. Adv Drug Deliv Rev (2016) 0.86
CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol (2014) 0.84
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. PLoS One (2015) 0.83
Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis. EBioMedicine (2017) 0.82
Fc glycan-modulated immunoglobulin G effector functions. J Clin Immunol (2014) 0.82
Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins. J Biol Chem (2016) 0.82
Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease. J Proteomics (2015) 0.81
Targeting the Fc receptor in autoimmune disease. Expert Opin Ther Targets (2014) 0.81
B-cell-independent sialylation of IgG. Proc Natl Acad Sci U S A (2016) 0.81
Glycans - the third revolution in evolution. Front Genet (2014) 0.80
Adaptive immunity to fungi. Cold Spring Harb Perspect Med (2014) 0.80
IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci Rep (2016) 0.80
Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs). Mol Cell Proteomics (2016) 0.79
Exploring the molecular basis of age-related disease comorbidities using a multi-omics graphical model. Sci Rep (2016) 0.79
The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution. PLoS One (2015) 0.79
The Association Between Glycosylation of Immunoglobulin G and Hypertension: A Multiple Ethnic Cross-Sectional Study. Medicine (Baltimore) (2016) 0.79
Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation. MBio (2014) 0.79
A sweet spot to control complement-induced inflammation. Nat Med (2012) 0.79
Carboxypeptidase E modulates intestinal immune homeostasis and protects against experimental colitis in mice. PLoS One (2014) 0.78
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. J Neuroinflammation (2015) 0.78
Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies. F1000Res (2013) 0.78
Immunoregulatory functions of immune complexes in vaccine and therapy. EMBO Mol Med (2016) 0.77
Glycosylation Profile of IgG in Moderate Kidney Dysfunction. J Am Soc Nephrol (2015) 0.77
Chemoenzymatic Glyco-engineering of Monoclonal Antibodies. Methods Mol Biol (2015) 0.77
IVIg attenuates complement and improves spinal cord injury outcomes in mice. Ann Clin Transl Neurol (2016) 0.77
Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G. PLoS One (2015) 0.77
Targeting B cells and autoantibodies in the therapy of autoimmune diseases. Semin Immunopathol (2014) 0.77
Mechanisms of Autoantibody-Induced Pathology. Front Immunol (2017) 0.76
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun (2016) 0.76
Antibody-mediated trapping of helminth larvae requires CD11b and Fcγ receptor I. J Immunol (2014) 0.76
A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immun Inflamm Dis (2014) 0.76
The Association Between Low Back Pain and Composition of IgG Glycome. Sci Rep (2016) 0.76
Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases. Sci Rep (2016) 0.76
Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity. Rev Med Virol (2013) 0.76
Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese population. Medicine (Baltimore) (2016) 0.75
Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products. Evid Based Complement Alternat Med (2015) 0.75
CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis. Arthritis Res Ther (2015) 0.75
Estrogens regulate glycosylation of IgG in women and men. JCI Insight (2017) 0.75
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. J Immunol Methods (2017) 0.75
A bone to pick with Fc gamma receptors. Ann Transl Med (2015) 0.75
Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans. Mol Cell Proteomics (2016) 0.75
Comment on "Regulation of immunity during visceral Leishmania infection" and further discussions about the role of antibodies in infections with Leishmania. Parasit Vectors (2016) 0.75
Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signalling. PLoS One (2017) 0.75
Effects of statins on the immunoglobulin G glycome. Biochim Biophys Acta (2017) 0.75
Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity. Front Immunol (2017) 0.75
High-resolution physicochemical characterization of different intravenous immunoglobulin products. PLoS One (2017) 0.75
[Glycosylation-dependent effector function of IgG antibodies]. Z Rheumatol (2012) 0.75
Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity? Nat Rev Rheumatol (2017) 0.75
The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains. Front Immunol (2017) 0.75
Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. Sci Rep (2017) 0.75
Fcgamma receptors as regulators of immune responses. Nat Rev Immunol (2008) 11.34
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science (2005) 6.48
Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol (2006) 6.36
Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity (2005) 6.21
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol (2009) 4.98
The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96
Modulation of the antitumor immune response by complement. Nat Immunol (2008) 4.53
Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A (2008) 3.55
Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med (1995) 3.38
Functional roles for C5a receptors in sepsis. Nat Med (2008) 3.33
Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature (2011) 3.32
The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol (2002) 3.09
Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science (1998) 2.95
The role of the anaphylatoxins in health and disease. Mol Immunol (2009) 2.95
A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med (2005) 2.80
Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat Methods (2006) 2.71
Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol (2008) 2.52
Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med (2009) 2.30
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest (2006) 2.15
C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest (2002) 2.11
IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest (2006) 1.77
Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med (2010) 1.62
C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol (2004) 1.57
The induction of inflammation by dectin-1 in vivo is dependent on myeloid cell programming and the progression of phagocytosis. J Immunol (2008) 1.56
Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep (2009) 1.49
Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest (2005) 1.38
NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat Chem Biol (2011) 1.30
Two signaling mechanisms for activation of alphaM beta2 avidity in polymorphonuclear neutrophils. J Biol Chem (1998) 1.28
C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol (2005) 1.26
C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J Biol Chem (2003) 1.22
Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J Cell Biol (1994) 1.19
Analyzing antibody-Fc-receptor interactions. Methods Mol Biol (2008) 1.19
IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice. J Immunol (1999) 1.18
In vivo functional analysis and genetic modification of in vitro-derived mouse neutrophils. FASEB J (2011) 0.93
Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. J Immunol (2010) 0.92
Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo. Eur J Immunol (2011) 0.92
N-glycan analysis of recombinant L-Selectin reveals sulfated GalNAc and GalNAc-GalNAc motifs. J Proteome Res (2010) 0.88
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol (2007) 8.92
Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science (2011) 8.53
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science (2006) 8.13
Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science (2010) 7.41
Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol (2006) 6.36
Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity (2005) 6.21
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature (2012) 5.84
Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science (2012) 5.34
Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med (2009) 5.27
Inflammation and cancer: how hot is the link? Biochem Pharmacol (2006) 5.17
An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol (2008) 5.13
Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med (2002) 4.87
Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69
ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods (2009) 4.69
Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med (2004) 4.45
Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol (2013) 4.33
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest (2012) 4.31
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science (2008) 4.11
Tissue-resident macrophages. Nat Immunol (2013) 4.09
A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res (2010) 3.89
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe (2009) 3.52
Waves of retrotransposon expansion remodel genome organization and CTCF binding in multiple mammalian lineages. Cell (2012) 3.48
Functional roles for C5a receptors in sepsis. Nat Med (2008) 3.33
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26
The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog (2005) 3.13
Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med (2009) 3.12
The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol (2002) 3.09
CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med (2005) 3.03
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99
Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97
The role of the anaphylatoxins in health and disease. Mol Immunol (2009) 2.95
Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87
Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood (2004) 2.84
Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83
A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med (2005) 2.80
Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol (2009) 2.74
Development and application of a salmonid EST database and cDNA microarray: data mining and interspecific hybridization characteristics. Genome Res (2004) 2.72
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol (2010) 2.70
Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (2006) 2.64
Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood (2002) 2.62
Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62
A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res (2006) 2.53
Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med (2003) 2.52
Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis (2009) 2.49
Tackling human fungal infections. Science (2012) 2.49
Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol (2009) 2.48
Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci (2006) 2.44
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43
Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol (2003) 2.38
Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol (2010) 2.38
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep (2013) 2.37
Foxa2 regulates alveolarization and goblet cell hyperplasia. Development (2004) 2.35
CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem (2008) 2.34
Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med (2007) 2.33
Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem (2005) 2.32
Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol (2003) 2.30
Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol (2003) 2.27
C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity (2005) 2.24
Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis (2007) 2.24
Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res (2005) 2.22
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci U S A (2005) 2.22
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat Genet (2005) 2.20
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med (2008) 2.19
Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest (2003) 2.17
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest (2006) 2.15
Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology (2014) 2.14
Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase. Glycobiology (2010) 2.14
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol (2012) 2.08
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity (2012) 2.06
Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med (2007) 2.03
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J Exp Med (2009) 2.03
A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res (2006) 2.02
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med (2006) 2.00
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet (2012) 2.00
The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol (2012) 1.97
Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med (2009) 1.97
An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet (2010) 1.95
PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal (2011) 1.95